logo

For the Inventor, By the Inventor

Tokyo, Japan

Nobuyoshi Iwata

USPTO Granted Patents = 10 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Hiromachi, JP (1987 - 1988)
  • Tokyo, JP (1987 - 1997)

Company Filing History:

goldMedal10 out of 613 
 
Sankyo Company, Limited
 patents
silverMedal1 out of 1,432 
 
Ube Industries, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1987-1997

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5643923 - Quinuclidinyloxy-isoxazole compounds and their therapeutic uses (1997-07-01),
2. 5321037 - Isoxazole derivatives for use as cerebro-active drugs and central muscle (1994-06-14),
3. 5262413 - Use of isoxazolin-3-one derivatives as antidepressants (1993-11-16),
4. 5217970 - Use of isoxazolin-3-one derivatives as antidepressants (1993-06-08),
5. 5116839 - Use of isoxazolin-3-one derivatives as antidepressants (1992-05-26),
6. 4981872 - Prostaglandin derivatives, their preparation and their therapeutic use (1991-01-01),
7. 4777184 - Prostaglandin derivatives, their preparation and use (1988-10-11),
8. 4749704 - Cyclopenta[d]pyrimidine derivatives and use as antidepressants (1988-06-07),
9. 4716162 - Fused 5 ring heterocyclic compounds, their preparation, and their (1987-12-29),
10. 4634706 - Griseolic acid derivatives, and their use as enzyme inhibitors (1987-01-06),

Title: Nobuyoshi Iwata: Innovator in Neurotherapeutic Compounds

Introduction

Nobuyoshi Iwata is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of neurotherapeutics. With a remarkable portfolio comprising 10 patents, Iwata’s work focuses on innovative compounds aimed at treating cognitive disorders, particularly in the growing field of Alzheimer's disease research.

Latest Patents

Among his latest patents, Iwata has developed quinuclidinyloxy-isoxazole compounds that possess therapeutic uses in treating and preventing cognitive disorders. These compounds can be expressed with the formula (I), showcasing various substituents that can be tailored for specific therapeutic effects. Another key patent includes isoxazole derivatives that serve as cerebro-active drugs, aimed at addressing cerebral circulatory problems and functioning as centrally acting muscle relaxants. These innovations hold great promise for enhancing treatment protocols for conditions such as senile dementia.

Career Highlights

Iwata has made significant strides in the pharmaceutical industry, working with esteemed companies like Sankyo Company, Limited and Ube Industries, Inc. His career is marked by a dedication to developing life-changing compounds that address major health concerns affecting the elderly population.

Collaborations

Throughout his career, Iwata has collaborated with noteworthy colleagues, including Mitsuo Nagano and Kenji Yoshimi. These partnerships have facilitated the advancement of his research and strengthened the impact of his innovative discoveries within the scientific community.

Conclusion

In summary, Nobuyoshi Iwata stands out as a vital contributor to the realm of neurotherapeutics. His patents embody a forward-thinking approach to addressing cognitive disorders, thus positioning him as an inventor of considerable importance in the ongoing fight against neurological diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…